Login / Signup
Petra Zahumenská
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 1
Top Topics
Renal Cell Carcinoma
Emergency Department
Poor Prognosis
Top Venues
Acta pharmaceutica (Zagreb, Croatia)
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Radek Indra
,
Sandra Jelínková
,
Katarína Kollárová
,
Petra Zahumenská
,
Josef Dvořák
,
Šárka Dušková
,
Helena Dračínská
The tyrosine kinase inhibitor lenvatinib is oxidized by rat cytochromes P450 and affects their expression in rat liver.
Acta pharmaceutica (Zagreb, Croatia)
74 (3) (2024)